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Measles infection and the host immune response to measles virus were compared using naive and immunized rhesus
monkeys. The monkeys were experimentally challenged with a wild-type strain of measles virus inoculated intranasally.
After pathogenic virus challenge, measles virus was detected in mononuclear cells of peripheral blood, lymph node, and
spleen in naive monkeys and viremia peaked on Day 7. However, only one of five vaccinated monkeys had a low virus titer
in peripheral blood mononuclear cells at one time point after challenge. No virus was detected in the lymphoid tissues from
an immunized monkey that was euthanized on Day 7 of infection. Measles-specific IgM, IgG, neutralizing antibody, and
cytotoxic T lymphocytes were detected in vaccinated monkeys before challenge, but antibody titers were significantly lower
in immunized monkeys than in naive monkeys after challenge. Measles-specific IgG antibody and cytotoxic T cell responses
were still detected more than 1 year after vaccination or infection. This animal model is useful for the further study of
measles pathogenesis, immunosuppression, and immunologic memory. q 1997 Academic Press
INTRODUCTION animal models for studies of the pathogenesis of measles
(Kawahora, 1965; Nii et al., 1964), immune suppression
Measles is a highly contagious infectious disease that
(Hicks et al., 1977; McChesney et al., 1989), analysis of
induces life-long immune protection. This protection
viral virulence (van Binnendijk et al., 1994; Yamanouchi et
seems to be based on the presence of antiviral neutraliz-
al., 1970), and vaccine-induced immune protection (En-
ing antibodies and specific cytotoxic T lymphocytes (CTL)
ders et al., 1960; Schwarz et al., 1960).
(Norrby, 1985). Measles virus, the etiologic agent, is a
In this study, measles virus load was quantitated from
negative-sense, single-strand RNA virus (Griffin and Bel-
blood, spleen, and lymph nodes by end-point dilution
lini, 1996). Vaccination with live attenuated virus has
co-culture with Raji cells. Anti-measles humoral immune
greatly reduced the number of cases of measles, but
responses and CTL activity were assayed after vaccina-
measles is still a major cause of serious disease and
tion and pathogenic virus challenge in rhesus monkeys.
infant mortality in developing countries due to low vac-
Measles virus-induced immune responses were com-
cine coverage and the inability to vaccinate infants in the
pared between naive and immunized monkeys postchal-
first 6 months of life (Anderson and May, 1985; Cutts and
lenge (pc). Naive monkeys had higher titers of virus and
Markowitz, 1994).
higher levels of antibodies than those of vaccinated mon-
Asian macaques can be infected experimentally with
keys after challenge. Both groups maintained long-term
measles virus by intranasal, intratracheal, or subcutane-
memory for both humoral and cellular immunity. Other
ous inoculation, and they develop clinical signs of mea-
results suggested that measles neutralizing antibody is
sles similar to those seen in humans (Blake and Trask,
important in preventing systemic infection after chal-
1921a,b). Further, although the immunologic correlates of
lenge, but that a measles-specific CTL response pre-
protective immunity against measles have not been estab-
vents clinical disease.
lished, adaptive immunity in the rhesus monkey against
measles has been clearly demonstrated (Blake and Trask, MATERIALS AND METHODS
1921c). Rhesus and cynomolgus monkeys have served as
Animals and viruses
Preparation of the measles challenge virus stock, im-1 To whom correspondence and reprint requests should be ad-
dressed. Fax: (916) 752-2880. E-mail: mbmcchesney@ucdavis.edu. munization of monkeys and challenge with measles virus
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were as described (McChesney et al., 1997). The Mora- Laboratory, Inc., Gaithersburg, MD), which were cross-
reactive with rhesus IgG and IgM, were used.ten vaccine strain (Attenuvax; Merck Sharp and Dohme,
West Point, PA) was administered as 0.5 ml subcutane-
Measles neutralization EIAously. For pathogenic virus challenge, the Davis 87 strain
of measles, prepared as 104.2 tissue culture infectious
A low-passage Edmonston virus (Albrecht et al., 1981)
doses 50% (TCID50) in 1 ml of phosphate-buffered saline was grown and plaqued in Vero cells in Dulbecco’s mini-
(PBS), was administered as one drop on each eye and
mal essential medium (Irvine Scientific) with 5% FCS.
the remainder was administered intranasally.
Neutralizing antibody to measles virus was measured as
described (Anderson et al., 1985; Erdman et al., 1991)
Quantitation of virus load in peripheral blood with modifications. Starting at 1/10, serial twofold dilu-
mononuclear cells (PBMC), plasma, and tissues tions of heat-inactivated (567 for 30 min) serum or plasma
were added to wells of a 96-well plate in duplicate, in
Heparinized blood samples were collected at 2, 4, 7,
50 ml, and mixed with an equal volume of freshly diluted
14, and 21 days pc and PBMC were isolated by density
measles virus containing 50 plaque-forming units. After
gradient centrifugation (Lymphocyte Separation Medium;
incubation for 1 hr at 377 in a 5% CO2 incubator, VeroOrganon Teknika Corp., Durham, NC) (Boyum, 1968). Se-
cells were added at 8 1 103 cells per well in 100 ml. The
rial 10-fold dilutions of PBMC or plasma were made in
plates were incubated for 3 days at 377 and 5% CO2 . TheRPMI 1640 (Irvine Scientific, Santa Ana, CA) supple-
culture wells were fixed with 80% acetone diluted in PBS
mented with 10% fetal bovine serum (FCS; Intergen Co.,
for 10 min at 47, plates were washed, and a 1:5000 dilu-
Purchase, NY), and 1% glutamine, penicillin, and strepto-
tion of biotinylated KK2 mAb was added to all wells. After
mycin (Sigma Chemical Co., St. Louis, MO). Four repli-
a 1-hr incubation, the plates were rinsed, and a 1:3000
cates of 101 to 105 PBMC were co-cultured with 2 1 105
dilution of streptavidin-peroxidase (Amersham Corp., Ar-
Raji cells per well in 24-well plates (Fisher, Santa Clara,
lington Heights, IL) was added to all wells and incubated
CA) and 1 1 106 PBMC were co-cultured with 1 1 106
at 377 for 20 min. After the final wash, the color develop-
Raji cells in T25 flasks. Culture medium was changed
ment was as described above. Neutralizing antibody ti-
every 3 to 4 days and cultures were maintained for 2
ters were calculated as the highest dilution showing 50%
weeks. All cultures were monitored for cytopathic effect
reduction in OD of control wells that contained virus with-
(CPE, large multinucleated giant cells) and scored posi-
out serum.
tive or negative by an indirect fluorescence assay (IFA)
using the KK2-mAb to measles nucleoprotein (Bellini et Detection of measles-specific CTL
al., 1986). Spleen, lymph nodes, and blood were collected
from animals that were euthanized on Day 7 after virus To detect primary measles-specific CTL, freshly pre-
pared PBMC were used directly in the CTL chromiumchallenge. Mononuclear cells were teased from spleen
and lymph nodes, and these cells were co-cultured with release assay. The in vitro restimulation and detection
of secondary CTL were performed as described (LohmanRaji cells as described above except that 1 1 107 cells
were also cultured. The titers of virus were expressed et al., 1994), with the following modifications. Antigen-
specific stimulator cells were Herpes papio-transformedas TCID50 per milliliter of plasma or per 10
6 cells using
the method of Reed and Muench (1938). autologous B cell lines infected with the Edmonston
strain of measles virus (American Type Culture Collec-
tion, Rockville, MD) at a multiplicity of infection (m.o.i.) ofMeasles-specific enzyme immunoassays (EIAs)
0.3 for 2 days in RPMI 1640 supplemented with 10% FCS
and antibiotics. About 90% of the B cells were positiveIgG and IgM EIAs were performed as previously de-
scribed (Erdman et al., 1991; Hummel et al., 1992), using for measles antigen by IFA after 48 hr of infection. The
cells were then fixed with paraformaldehyde (Sigma) asthe measles nucleoprotein (N) expressed by baculovirus
as positive control antigen and spodoptera frugiperda described (Van Baalen et al., 1993). After the final wash,
the cells were counted, centrifuged, and resuspended in(Sf9) cell lysate as a negative control antigen. Serum or
plasma samples were diluted to 1/100 and then serially RPMI 1640 with 10% FCS.
PBMC isolated from heparinized blood were cryopre-diluted 1 to 4. The results were interpreted as positive if
(1) the difference between the mean optical density (OD) served in liquid nitrogen until used. After thawing, PBMC
were co-cultivated with the fixed stimulator cells at thevalues of duplicate N wells and duplicate Sf9 wells was
⁄0.1 and (2) the mean OD of N wells divided by the mean ratio of 1 stimulator cell to 10 PBMC, with cell densities
of 2 1 106 to 3 1 106 cells per well in a 24-well plateOD of Sf9 wells was ⁄3. Antibody titers were defined as
the highest reciprocal dilution that was positive. Goat in CTL culture medium supplemented with 1% rhesus
measles-immune serum. The cultures were grown for 2anti-human IgM antibody (Orgenon Teknika Corp.) and
goat anti-human IgG peroxidase (Kirkegaard & Perry weeks before the CTL assay. For the CTL assay, target
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cells were infected with the Edmonston virus or mock-
infected, as described above. Effector (E) and target (T)
cells were added together at multiple E/T ratios in a 4-
hr chromium release assay, and percentage of specific
lysis was calculated from supernatant chromium mea-
sured in a beta counter (Microbeta 1450, Wallac Biosys-
tems, Gaithersburg, MD) by the following formula: 100 1
[(experimental release0 spontaneous release)/(maximal
release 0 spontaneous release)]. Spontaneous release
was measured from target cells alone incubated in 100
ml medium, and maximal release was measured from
target cells incubated in 100 ml detergent: 5% sodium
dodecyl sulfate (Sigma) and 0.5% Triton X-100 (Sigma).
Specific lysis was considered positive if the lysis of in- FIG. 2. Measles virus levels in two monkeys on Day 7 after patho-
genic virus challenge. Monkey 27585 was a naive animal and monkeyfected targets was greater than twofold above the lysis
27493 was immunized with the Moraten vaccine before challenge. Viralof mock-infected targets, and if it was at least 10%. To
load in PBMC, spleen, and lymph node cells was quantified by endpointdeplete CD4 or CD8/ T cells, the effector cells were
dilution co-culture and the level of detection was 1 in 107 cells, as
preincubated for 30 min with an anti-CD8 mAb or an anti- described under Materials and Methods.
CD4 mAb coated to magnetic beads (Dynabeads, Dynal,
Norway) according to the manufacturer’s instructions.
Then the bead-coated cells were removed with a magnet lated with the Moraten vaccine strain and they were
and the remaining cells were placed in the CTL assay. boosted after 4 months. Five naive monkeys were simi-
larly housed. At 1 year after the primary vaccination, allStatistical analysis
10 monkeys were challenged with the Davis 87 strain of
We evaluated the difference in IgG antibody titers of
measles virus conjunctivally/intranasally. From the naivenaive and vaccinated monkeys at 12 weeks postchal-
monkeys, measles virus was detected in PBMC as earlylenge. Testing for statistical significance was performed
as 2 days pc, and the peak of viremia was on Day 7 (Fig.using a t test carried out on the coded titers (Snedecor
1). The virus was cleared very quickly, as there was noand Cochran, 1967).
detectable viremia from three of four naive monkeys at
RESULTS 3 weeks pc (Fig. 1). Cell-free virus in plasma was de-
Comparisons of viral load in the naive host and the tected from three of the four naive monkeys. Plasma
vaccinated host after challenge with the Davis 87 viremia peaked on Day 7, at 1 to 2 logs below cell-
strain of measles virus associated virus levels, and it was undetectable at 2
weeks pc (data not shown). Thus cell-free virus was elim-In order to compare measles virus replication in the
inated faster than cell-associated virus in the naive mon-naive and the immunized host, five monkeys were inocu-
keys. In contrast to the naive monkeys, virus was de-
tected in the PBMC of only one of the five vaccinated
monkeys and only on Day 4 p.c. The virus titer was 100
to 1000 times lower than in the naive monkeys (Fig. 1).
Plasma viremia was not detected in any vaccinated ani-
mals (data not shown).
The mononuclear cells from spleen, lymph node, and
blood of one vaccinated and one naive monkey that were
euthanized on Day 7 pc were co-cultivated with Raji cells.
As shown in Fig. 2, the naive monkey, 27585, had high
titers of measles virus in all three lymphoid tissues, but
the virus titer in the lymph node was 1 log higher than
those in spleen and PBMC. No virus was detected from
the tissues of the vaccinated monkey, 27493 (Fig. 2).
FIG. 1. Measles virus load after pathogenic measles virus challenge.
Antibody responses to measles virus in naive andOpen symbols represent four naive monkeys (the symbol h represents
vaccinated monkeysmonkey 27590; L, 27591; s, 27762; and n, 27587). Only one vaccinated
animal had viremia after challenge (the symbol j represents monkey
Anti-N specific IgM antibodies were detected in three27417). Viral load in PBMC was quantified by end point dilution co-
of four naive monkeys on Day 7 pc (Fig. 3A). All naiveculture, and the level of detection was 1 in 106 cells, as described
under Materials and Methods. monkeys developed high levels of IgM, which peaked at
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weeks pv and peaked at 4 weeks pv. In two of four
vaccinated monkeys, IgG antibody titers increased pc
and returned to low levels around 3 weeks after chal-
lenge, whereas the antibody titers remained stable in the
other two vaccinated animals before and after challenge
(Table 1). IgG antibody titers of the naive monkeys were
significantly higher than those of vaccinated animals at
12 weeks pc (P  0.005; Table 1). Measles neutralizing
antibody appeared in all vaccinated animals at 2 weeks
pv (Table 2). After boosting, the neutralizing antibody ti-
ters were increased fourfold or greater in all immunized
animals. Nine months later, prior to pathogenic virus
challenge, the measles neutralizing antibody titers had
declined to a low level in three of four monkeys. After
challenge, two animals had significant elevations in anti-
body titer, followed by a decline to prechallenge levels.
These were the same animals with elevated anti-N IgG
described above. Monkey 27417 had the lowest neu-
tralizing antibody titer before challenge, developed vire-
mia after challenge, and had the highest titer of antibody
at 2 weeks pc (Table 2).
Measles-specific CTL responses in naive and
vaccinated monkeys
After pathogenic virus challenge, measles-specific
CTL activity was detected in the PBMC of all animals
tested (data not shown). However, we could not detect
measles-specific primary CTL in the peripheral blood at
1 or 2 weeks postchallenge (lymphocytes activated in
vivo and assayed without restimulation in vitro). Low lev-
els of measles antigen-specific CTL activity were de-
tected in PBMC of all four vaccinated animals as early
as 4 weeks after the initial immunization with the MoratenFIG. 3. Kinetics of measles-specific IgM (A), IgG (B), and neutralizing
virus. CTL activity was still detectable after boosting andantibody (C) in four naive monkeys after pathogenic measles virus
challenge. The symbols for the animals are the same as in Fig. 1. Serial immediately prior to challenge (9 months after boosting).
fourfold dilutions were performed for the IgM and IgG assays, and A measles-specific CTL response was detected in naive
twofold dilutions were performed for neutralizing antibody titration. monkeys at 4 weeks and 1 year after challenge (data not
shown). CTL responses were also detected in lymphoid
tissues at 3 months pc (data not shown). These results
2 weeks pc. IgM levels declined to very low or undetect- are evidence for long-lived T cell memory in either the
able levels at 12 weeks pc (Fig. 3A). In contrast to the measles-infected or the vaccinated host.
kinetics of IgM, anti-N IgG antibodies appeared at 2 To identify the phenotype of the CTL effector cells, the
weeks pc and reached peak titer at 3 weeks pc (Fig. 3B). cells were separated into CD4 or CD8-depleted fractions.
IgG titers were maintained at high levels for 12 weeks The CD4-depleted cells exhibited measles virus-specific
(Fig. 3B, Table 1). The naive monkeys still had high levels lysis; in contrast, very low specific lysis was detected
of IgG antibodies 1 year pc (data not shown). Measles using CD8-depleted cells (Fig. 4). This demonstrated that
virus neutralizing antibody coincided with anti-N IgG anti- the major CTL phenotype was CD8/ (CD4-depleted).
bodies, following the pattern of appearance at 2 weeks, From some monkeys, CD8-depleted effector cells medi-
rising to high levels 1 week later, and remaining stable ated antigen-specific lysis; thus we also detected CD4/
over 12 weeks (Fig. 3C). CTL after in vitro restimulation.
In vaccinated monkeys, anti-NP IgM antibodies were
detected at 2 and 4 weeks postvaccination (pv), but IgM
DISCUSSION
could not be detected postboost or postchallenge and
antibody levels were lower than those of naive monkeys Here we have demonstrated that a currently used, live-
attenuated measles vaccine induced both humoral im-(data not shown). IgG antibodies were detected at 2
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TABLE 1
Measles-Specific IgG Antibody Titers in Naive and Immunized Monkeys
Monkey No. Prechallenge 1 week pca 2 weeks pc 3 weeks pc 12 weeks pc
27591b 0 0 400 6,400 6400
27590b 0 0 1,600 6,400 6400
27762b 0 0 100 1,600 6400
27587b 0 0 400 25,600 6400
27504c 400 400 400 400 400d
27539c 1600 1600 1,600 1,600 1600d
27417c 400 1600 25,600 400 400d
27686c 1600 400 6,400 6,400 1600d
a Postchallenge.
b Naive monkeys.
c Immunized monkeys.
d P  0.005.
munity and cellular immunity which were similar in qual- had high levels of virus in PBMC, and viremia peaked
on Day 7 pc (Fig. 1). This observation is similar to thoseity to the immunity induced by pathogenic measles infec-
tion, and we demonstrated that the vaccinated monkeys of two recent studies of measles in monkeys (Kobune et
al., 1990; van Binnendijk et al., 1994). All naive monkeyswere protected from measles after exposure to wild-type
measles virus. After challenge, the naive monkeys devel- developed a skin rash between Day 7 and Day 10, as
also reported by others (Enders et al., 1960; Kobune etoped infection and inflammatory disease (McChesney et
al., 1997) which was similar to human measles, and their al., 1996), at the time that viremia began to decrease.
This suggests that the appearance of the rash is coinci-immune responses tended to be stronger than the vac-
cine-induced responses. The chief mode of measles vi- dent with the initiation of virus clearance and that both
phenomena are a function of T cell immunity (Burnet,rus transmission is via aerosol and then the virus enters
through the respiratory tract. In order to model primary 1968). Measles virus was eliminated from blood around
3 weeks pc, but others have reported that measles virusmeasles infection of the respiratory tract, rhesus mon-
keys were inoculated with a pathogenic virus conjuncti- is cleared from the blood of cynomolgus macaques by
Day 14 (Kobune et al., 1990). The longer duration of vire-vally and intranasally in our experiments. Thus we found
that one vaccinated animal with low-level neutralizing mia in our animal model may be due to (1) the difference
of monkey species used (McChesney et al., 1997), (2)antibody prior to challenge developed a systemic, though
clinically silent, infection after respiratory challenge. Fi- differential virulence of challenge virus stocks, or (3) dif-
ferent sensitivities in the growth of wild-type measlesnally, long-term humoral and cellular immune responses
to measles virus were detected both in vaccinated ani- isolates between the Raji cell line and the B95-8 cells
(Kobune et al., 1990). High titers of measles virus weremals prior to challenge and in naive monkeys after chal-
lenge. isolated from spleen and lymph nodes, as reported pre-
viously (Kobune et al., 1996), but we found that lymphAfter pathogenic virus challenge, all naive monkeys
TABLE 2
Measles Neutralizing Antibody Titersa of Rhesus Monkeys after Vaccination and after MV Challenge
Time
Monkeys preb 2 weeks pv Boost 2 weeks pb Challenge 2 weeks pc 12 weeks pc
27504 10 1280 640 5120 640 1280 640
27539 10 160 1280 5120 2560 5120 2560
27417c 10 1280 320 1280 320 10240 1280
27686 10 320 320 2560 640 5120 1280
a Reciprocal of antibody titers. The first dilution was 1/10 and subsequent dilutions were twofold. Fourfold changes in titer from the previous time
point are underlined.
b pre, before vaccination; pv, postvaccination; boost, second vaccination; pb, postboost; pc, postchallenge.
c The only vaccinated monkey that had viremia pc.
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that weak CTL responses detected after pathogenic virus
challenge were due to changes in CTL epitopes between
Davis 87 and the Moraten vaccine (Rota et al., 1994).
However, the CTL responses detected after immuniza-
tion were within a relatively homogenous system be-
cause the Moraten vaccine virus is derived from the
Edmonston strain and they are genetically similar. We
cannot accurately quantify the CTL response after re-
stimulation in bulk cultures, so we could not compare
the strength of CTL responses after vaccination and
after challenge. Precursor frequency analysis of limiting
dilution cultures is in progress to quantify the CTL re-
sponse. The phenotype of measles virus-specific CTL
in humans is a matter of controversy. In some studiesFIG. 4. Measles virus-specific CTL detected from an immunized mon-
key, 27539, at 4 weeks postboost. Fresh PBMC were stimulated with it was concluded that CD4/, MHC class II-restricted T
fixed measles virus-infected autologous B cells and tested against cells are important (Jacobson et al., 1984, 1989; Wu
mock-infected (open symbols) or measles-infected (filled symbols) au- et al., 1993), but in other reports, CD8/, MHC class I-
tologous B cells, as described under Materials and Methods. (j)
restricted T cells were predominant in the measles CTLPBMC; (l) CD4/ depleted effector cells; and (l) CD8/-depleted ef-
response (Nanan et al., 1995; van Binnendijk et al.,fector cells in the CTL assay. The E/T ratios for CD8/-depleted effector
cells were reduced due to the number of cells available. 1990). In our experiments, CD8/ T cells mediated spe-
cific lysis in most cases, but CD8/ and CD4/ T cell-
mediated lysis was detected in some monkeys. Thus
nodes had more virus than did spleen and PBMC on Day both CD4/ and CD8/ T cells may have cytotoxic activity
7 pc. Three of four naive monkeys had plasma viremia after secondary in vitro restimulation, as previously re-
that disappeared before the appearance of neutralizing ported (van Binnendijk et al., 1989). We failed to detect
antibody and IgG, as reported previously (Peebles, 1967). primary measles CTL responses at 1 and 2 weeks pc
Comparisons of serum antibody responses following and we hypothesize that most anti-measles CTL are
vaccination and pathogenic virus challenge showed that localized in the lymphoid tissues, lung, and gut during
measles virus-specific antibody titers were lower in vac- the acute phase of infection.
cinated monkeys than in pathogenic virus-infected naive The relative roles of humoral and cellular immunity to
monkeys, as observed in humans (Christenson and Bot- measles virus in vaccine-induced protection remain a
tiger, 1994; Eghafona et al., 1991) and in cynomolgus matter of speculation (Hilleman, 1994). Monkey 27417
macaques (Enders et al., 1960). All four vaccinated mon- developed subclinical systemic infection and high-titer
keys had low levels of neutralizing antibody 3 months neutralizing antibody after challenge; interestingly, this
after vaccination; after boosting, the titers increased sig- monkey had the lowest titer of neutralizing antibody prior
nificantly (Table 2), but then declined to previous levels to challenge (Table 2), and it also had a measles virus-
by 4 weeks postboost (data not shown). There are sev- specific CTL response prior to challenge (not shown). It is
eral similar observations in humans (Christenson and unlikely that parenteral immunization with an attenuated
Bottiger, 1994; Cohn et al., 1994; Markowitz et al., 1992) measles vaccine would induce long-lived neutralizing
and in cynomolgus monkeys (Enders et al., 1960). Recur- IgG or IgA antibodies in the respiratory tract that could
rent measles exposure may cause subclinical infection prevent a primary infection. Enders et al. (1960) observed
of the respiratory tract or even asymptomatic systemic that vaccinated monkeys were protected from measles
infection as in one of five vaccinated monkeys in the challenge, but that infectious virus was recovered from
present study. This recurrent infection may boost anti- the oropharynx. We speculate that neutralizing antibody
measles immune responses (Norrby and Oxman, 1990), is important in preventing systemic infection following a
but we cannot explain why the increase is only transient. primary infection in the respiratory tract after exposure
Measles-specific CTL responses were detected from to wild-type measles virus. On the other hand, the CTL
4 weeks pv to more than 1 year pv, but the response was response to measles virus cannot prevent primary infec-
weak compared with the response in humans (Nanan et tion, but it can prevent the spread of infection. As was
al., 1995; van Binnendijk et al., 1990). In our laboratory, we deduced from experiments of nature, cellular immunity
also find that CTL responses to simian immunodeficiency is closely related to the recovery from measles virus
virus (SIV) are weak in SIV-infected rhesus monkeys and infection and the prevention of serious disease (Burnet,
not as strong as those in humans infected with HIV (Loh- 1968; Good and Zak, 1956).
man et al., 1994). The Edmonston virus was used to Since measles virus continues to kill over one and a
half million infants and children each year, and currentlyrestimulate CTL and to infect target cells, so it is possible
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Hicks, J., Sullivan, J., and Albrecht, P. (1977). Immune responses duringlicensed vaccines are not effective in young infants, this
measles infection in immunosuppressed rhesus monkeys. J. Immu-animal model is valuable in the further study of measles
nol. 119, 1452–1456.
pathogenesis, the mechanisms of long-term immuno- Hilleman, M. R. (1994). Vaccinology, immunology, and comparative
logic memory, and the development of a new measles pathogenesis of measles in the quest for a preventative against
vaccine which could be effective in the presence of ma- AIDS. Aids Res. Hum. Retroviruses 10, 3–12.
Hummel, K. B., Erdman, D. D., Heath, J., and Bellini, W. J. (1992). Bacu-ternal neutralizing antibody.
lovirus expression of the nucleoprotein gene of measles virus and
utility of the recombinant protein in diagnostic enzyme immunoas-
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